Track Your CD4 Count and Viral Load! Use TheBody.com's New Health Tracker!

BROWSE TOPICS IN HIV TREATMENT:

HIV Treatment: Home Page

Just Diagnosed

HIV Medications

First Steps to Treatment

HIV Drug Resistance

Switching or Stopping Treatment

Third Line/Rescue Treatment

Hepatitis C Coinfection

Women & Pregnancy

HIV Treatment for Children

Side Effects & Health Problems

Research & Experimental Drugs

HIV Treatment in the Developing World

Vaccines (for HIV Prevention)

The Basics | Clinical Trials | Initiatives & Recommendations | Activism | Findings

Show Archived (Historical) Articles

The Basics

HIV Vaccine Awareness Day May 18, 2009 (May 18, 2009)
From National Institute of Allergy and Infectious Diseases
Piecing Together the HIV Prevention Puzzle (May 18, 2009)
AVAC report assesses progress in AIDS vaccine, microbicide and PrEP research and calls for urgent coordination and leadership in advance of upcoming results.
To read PDF, click here
From AIDS Vaccine Advocacy Coalition
London's Times Examines Test Aimed at Detecting Potential HIV/AIDS Vaccines (April 28, 2009)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
IAVI Report (PDF) (March-April 2009)
From International AIDS Vaccine Initiative
Newly Created Institute "Rare Bit of Good News" In HIV/AIDS Vaccine Efforts, Editorial Says (March 30, 2009)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
HIV Vaccine Development in 2009: Looking Back (and Forward) (February 11, 2009)
Mitchell Warren, the top dog at the AIDS Vaccine Advocacy Coalition, talks about the current state of vaccine development. He explains why, in his opinion, hope on the vaccine front is far from lost.
In The 16th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
Understanding the Immune System (2009)
From International AIDS Vaccine Initiative
Understanding the Conundrum of Immune Activation in HIV/AIDS (January 2009)
From International AIDS Vaccine Initiative
Understanding Innate Immunity and HIV (December 2008)
From International AIDS Vaccine Initiative
Statement of Anthony S. Fauci, M.D., on HIV Vaccine Awareness Day (May 18, 2008)
From National Institute of Allergy and Infectious Diseases
2008 AVAC Report The Search Must Continue (May 2008)
From AIDS Vaccine Advocacy Coalition
Understanding Cellular Immune Responses (April 2008)
From International AIDS Vaccine Initiative
Scientists No Closer to Developing HIV Vaccine Than 20 Years Ago, AAAS President Says (February 19, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
IAVI Report Online (2008)
A report on all aspects of AIDS vaccine research and associated scientific disciplines.
From International AIDS Vaccine Initiative
An Update Regarding the HVTN 502 and HVTN 503 HIV Vaccine Trials (October 23, 2007)
From U.S. National Institute of Allergy and Infectious Diseases
Questions and Answers: HVTN 502 and HVTN 503 HIV Vaccine Clinical Trials (October 23, 2007)
From U.S. National Institute of Allergy and Infectious Diseases
Philadelphia Inquirer Examines Effect of Merck's Failed International HIV Vaccine Trial on Research and Development (October 9, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Why Is There Still No Vaccine for HIV? (Summer 2007)
To read PDF, click here
In ACRIA Update, from AIDS Community Research Initiative of America
NIAID Statement on HIV Vaccine Awareness Day (May 18, 2007)
From U.S. National Institute of Allergy and Infectious Diseases
The Quest for an Effective HIV Vaccine Presents New Possibilities, Challenges (May 16, 2007)
From U.S. National Institute of Allergy and Infectious Diseases
On HIV Vaccine Awareness Day, Researchers and Activists Mark 10 Years of Hunting (May 11, 2007)
In Southern Voice

Clinical Trials

International AIDS Vaccine Research Database of AIDS Vaccines in Human Trials (Regularly Updated)
From International AIDS Vaccine Initiative
Clinical Trials in South Africa Help Fight HIV/AIDS (May 26, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Rochester Democrat and Chronicle Examines Area's HIV/AIDS Vaccine Efforts (May 8, 2009)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
NIAID Director Fauci Cancels Planned HIV Vaccine Trial (July 18, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Seattle Post-Intelligencer Examines Reactions of People Who Participated in Merck's Canceled HIV Vaccine Trial (November 12, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Large-Scale Trial of Merck's Experimental HIV Vaccine to Begin in South Africa (February 9, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation

Initiatives & Recommendations

Center for HIV-AIDS Vaccine Immunology (Regularly Updated)
AIDS Vaccine Report Calls for Full Research Funding (May 19, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Search for Pediatric Vaccine Critical to Creating a Generation Free of HIV (May 18, 2009)
Foundation to award grants totaling $1 Million for pediatric HIV vaccine research.
From Elizabeth Glaser Pediatric AIDS Foundation
HIV Vaccine Development Faces Several Scientific Obstacles, Fauci Says in Opinion Piece (April 1, 2009)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Boston Technology Business Owner Makes $100 Million Donation to HIV/AIDS Vaccine Research (February 4, 2009)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
TAG's Response to NIAID "Request for Information" on Priorities in Basic HIV Vaccine Research (June 4, 2008)
From Treatment Action Group
PAVE Gives Pause: Position Statement on the Proposed PAVE100A Vaccine Trial (May 30, 2008)
From Treatment Action Group
Updated, Annotated Preventive Vaccine Pipeline Table (May 29, 2008)
Information on the current preventive HIV vaccine pipeline, annotated with commentary and links to published and presented data.
From Treatment Action Group
More Human Clinical Research on HIV Vaccine Needed to Find "Magic Formula," Says Opinion Piece (April 14, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Newspapers Publish Opinion Piece, Letter to Editor Responding to Suggestions on Future of HIV Vaccine Research (April 11, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
HIV/AIDS Vaccine Researchers at NIH Meeting Call for Increase in Basic Research, New Strategies (March 26, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
U.S. Should Fund HIV/AIDS Strategies "That Work," Not "Expensive Vaccine Research," Opinion Piece Says (March 25, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Gates Foundation, Canadian Government Announce Joint Initiative to Develop HIV/AIDS Vaccine (February 21, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Ads Urge Youths to Help End AIDS by Volunteering for Vaccine Studies (October 11, 2006)
From National Institute of Allergy and Infectious Diseases
Gates Foundation Pledges $287 Million for HIV Vaccine Research (July 20, 2006)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
African Americans: Answers About HIV Vaccine Research (June 2006)
To read PDF, click here
From U.S. National Institute of Allergy and Infectious Diseases

Activism

HIV Vaccine Awareness Day 2005: Statement by NIAID Director Anthony S. Fauci (May 18, 2005)
From U.S. National Institute of Allergy and Infectious Diseases
Men Inspiring Hope: Eighth Annual HIV Vaccine Awareness Day Focuses on Men Who Have Sex With Men (May 17, 2005)
From U.S. National Institute of Allergy and Infectious Diseases
Vaccine Trial RV144 Squanders Public Goodwill and Scarce Research Funds -- But to What End? (January 2005)
An AIDS advocacy group questions the wisdom of RV144, an ongoing "prime-boost" Phase III vaccine trial in Thailand.
In TAGline, from Treatment Action Group
IAVI Statement on 2004 HIV/AIDS Statistics: New Technologies Key to Prevention (November 23, 2004)
Vaccines and microbicides could be key to reversing the growing HIV rate among women worldwide, the International AIDS Vaccine Initiative says.
From International AIDS Vaccine Initiative
Seventh Annual HIV Vaccine Awareness Day Highlights Slow Progress on Development (May 18, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Atlanta to Hold Events for HIV Vaccine Awareness Day (May 17, 2004)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Brother-to-Brother Receives Funds to Raise Awareness About HIV Vaccine Research in Hard-to-Reach Populations (March 26, 2004)
To read PDF, click here
In STEP Ezine, from Seattle Treatment Education Project

Findings, 2000 - Present

Researchers Develop Vaccine Candidate That Is Successful in Blocking Simian Version of HIV (May 18, 2009)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
AIDS Vaccine Research and Advocacy: An Update (Winter/Spring 2009)
To read PDF, click here
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
Duke Scientists Find Rare, Potent Antibody to HIV-1 (February 23, 2009)
From Duke Medicine
HIV Vaccine Development in 2009: Looking Back (and Forward) (February 11, 2009)
Mitchell Warren, the top dog at the AIDS Vaccine Advocacy Coalition, talks about the current state of vaccine development. He explains why, in his opinion, hope on the vaccine front is far from lost.
In The 16th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
Summit on HIV Vaccine Research and Development (March 25, 2008)
This is a webcast of the meeting.
From U.S. National Institute of Allergy and Infectious Diseases
The Failed HIV Vaccine, the HPV Vaccine Hullabaloo and the Future of HIV Prevention (January 2008)
To read PDF, click here
In HHS Watch, from Community HIV/AIDS Mobilization Project
Merck HIV Vaccine Trial Results: Hopes Dim for Struggling Field (Winter 2008)
To read PDF, click here
In TAGline, from Treatment Action Group
Leaders of Merck's Canceled HIV Vaccine Study Notify Participants Whether They Received Vaccine, Placebo (November 14, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Merck Halts International HIV Vaccine Trial (September 24, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Vaccination and Enrollment Are Discontinued in Phase II Trials of Merck's Investigational HIV Vaccine Candidate (September 21, 2007)
From Merck & Co., Inc.
Predicting the Impact of a Partially Effective HIV Vaccine and Subsequent Risk Behavior Change on the Heterosexual HIV Epidemic in Low- and Middle-Income Countries: A South African Example (September 1, 2007)
In Journal of Acquired Immune Deficiency Syndromes
AIDS Vaccine Update (July-December 2007)
Disappointment and questions after candidate fails in the STEP study.
In GMHC Treatment Issues, from Gay Men's Health Crisis
Male Circumcision Reduces Men's HIV Infection Risk by 65%, Data Re-Evaluation Says (February 23, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Scientists Unveil Piece of HIV Protein That May Be Key to AIDS Vaccine Development (February 14, 2007)
From U.S. National Institute of Allergy and Infectious Diseases
VAX Primer: Understanding the Early Stages of HIV Infection (April 2006)
How can studying what happens immediately following HIV infection help researchers design an AIDS vaccine?.
From International AIDS Vaccine Initiative
Enrolling Women Into HIV Preventive Vaccine Trials: An Ethical Imperative but a Logistical Challenge (February 21, 2006)
In PLoS Medicine

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.